These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Michigan's next wave of biopharmaceutical entrepreneurship. Kerppola R; van de Walle M; Surine S Nat Biotechnol; 2003 Sep; 21(9):1109-11. PubMed ID: 12949575 [No Abstract] [Full Text] [Related]
24. Biotechs hold their own in shifting industry. Mitchell P Nat Biotechnol; 2002 Nov; 20(11):1065-6. PubMed ID: 12410238 [No Abstract] [Full Text] [Related]
25. Evolution and future of biopharmaceuticals. Health Aff (Millwood); 2006; 25(5):1270. PubMed ID: 16966722 [No Abstract] [Full Text] [Related]
26. A rollercoaster ride. Jacobs T Nat Biotechnol; 2006 Mar; 24(3):284. PubMed ID: 16525390 [No Abstract] [Full Text] [Related]
27. The challenges of product- and process-related impurities to an evolving biopharmaceutical industry. Bracewell DG; Smales CM Bioanalysis; 2013 Jan; 5(2):123-6. PubMed ID: 23330553 [No Abstract] [Full Text] [Related]
37. Going it alone. Senior M Nat Biotechnol; 2014 May; 32(5):411-4. PubMed ID: 24811507 [No Abstract] [Full Text] [Related]
38. The biotechnology sector's craving for commercial expertise is fuelling a cultural exchange with drug industry. Smaglik P; Frantz S Nature; 2003 Apr; 422(6931):542-3. PubMed ID: 12673255 [No Abstract] [Full Text] [Related]
39. How Indian biotech is driving innovation. Nogrady B Nature; 2018 Dec; 564(7735):S53-S55. PubMed ID: 30542184 [No Abstract] [Full Text] [Related]
40. Monoclonal antibody: the corner stone of modern biotherapeutics. Xia ZN; Cai XT; Cao P Yao Xue Xue Bao; 2012 Oct; 47(10):1275-80. PubMed ID: 23289138 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]